|Bid||73.13 x 100|
|Ask||73.16 x 100|
|Day's Range||71.25 - 73.38|
|52 Week Range||62.56 - 93.50|
|PE Ratio (TTM)||28.42|
|Earnings Date||May 7, 2018 - May 11, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||77.50|
Akorn (AKRX): Shares tumbling here, down over 33%. It’s bad news for the generic drugmaker, as Germany’s Fresenius is ditching its plan to buy Akorn following allegations of breaches of FDA data integrity rules. Henry Schein (HSIC): Shares climbing in early trade, up around 6%. The health care products maker is going to spin off and merge its Animal Health business with startup Vets First Choice, an online platform for veterinarians. Merck (MRK): Shares up here in early trade, down around 2%. Rounding out our third health care related stock here, Merck shares are rallying following a rare double-upgrade by Goldman to Conviction Buy, citing its Keytruda lung cancer breakthrough. For more on today's big stock movers check out the Final Round, live at 3:55 p.m. ET, right here on Yahoo Finance.
NEW YORK, NY / ACCESSWIRE / April 23, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Henry Schein, Inc. ("Henry Schein" or the ...
NEW YORK, NY / ACCESSWIRE / April 23, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Henry Schein, Inc. ("Henry Schein" or the "Company") (HSIC) and certain of its officers. The class action, filed in United States District Court, Eastern District of New York, is on behalf of a class consisting of investors who purchased or otherwise acquired securities of Henry Schein between March 7, 2013, and February 12, 2018, both dates inclusive (the "Class Period"). Plaintiff seeks to recover compensable damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder.
The toymaker reported adjusted quarterly profit of 10 cents per share , compared to a consensus forecast of 33 cents a share. Revenue was also well below forecasts, with Hasbro citing the liquidation of Toys 'R' Us as a significant negative event for its results. Henry Schein HSIC – The provider of products and services to health-care offices will spin off its animal health business and merge it with that of Vets First Choice, a provider of services to veterinary practices.
Henry Schein Inc. shares rose 1.4% in premarket trade Monday after the company said it plans to spin off its animal health business for an expected $1 billion to $1.25 billion in tax-free cash. The company said it may use the tax-free cash for share buybacks, debt repayment and acquisitions. The company's animal health business will merge with privately-held Vets First Choice, with plans to form a company called Vets First Corp. and go public.
Henry Schein Inc said on Monday it would spin off its animal health business and merge it with Vets First Choice to create a new company that will form an animal health service and technology platform to support the veterinary market. The company said Henry Schein shareholders will own approximately 63 percent of the new company and expects to receive between $1.0 billion to $1.25 billion in cash on a tax-free basis. Vets First Choice, founded in 2010, is a provider of technology-enabled health care services, with focus on animal health.
Henry Schein is spinning off its animal health business and merging it with Vets First Choice to form a new company called Vets First Corp. The deal, which is expected to be announced Monday morning, would combine Henry Schein's veterinary supplies, software for practices and distribution network with Vets First Choice's prescription management platform. Health-care products distributor Henry Schein HSIC is spinning off its animal health business and merging it with Vets First Choice to form a new company called Vets First Corp.
- Henry Schein Will Spin Off Its Animal Health Business, Which Will Merge with Vets First Choice Forming an Independent Public Company - Transaction Unlocks Value for Henry Schein Shareholders by Creating ...
NEW YORK, NY / ACCESSWIRE / April 21, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Henry Schein, Inc. ("Henry Schein" or the "Company") (NASDAQ: ...
NEW ORLEANS, April 20, 2018-- Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 7, 2018 to file lead plaintiff ...
NEW YORK, NY / ACCESSWIRE / April 20, 2018 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New ...
NEW YORK, NY / ACCESSWIRE / April 20, 2018 / Pawar Law Group reminds shareholders who purchased shares of Henry Schein, Inc. (HSIC) from March 7, 2013 through February 12, 2018, both dates inclusive ("Class Period") of the important May 7, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Henry Schein investors under the federal securities laws. To join the Henry Schein class action, go to http://pawarlawgroup.com/cases/henry-schein-inc/ or call Vik Pawar, Esq.
NEW YORK, NY / ACCESSWIRE / April 18, 2018 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Henry Schein, ...